Skip to content
OpenCapital
Get started

ENDRA Life Sciences Inc. NDRA Q1 2026 Annual earnings

Reported May 18, 2026 · Before market open

EPS-$1.09Beat by $0.14
EPS estimate-$1.23

Next report

Aug 13, 2026 (In 2 weeks)
Revenue estimate$100.0K
EPS estimate-$0.84

Versus estimates

Revenue

Q4 2024$211.6K

Diluted EPS

Q1 2026-$1.09Beat by $0.14
Q4 2025-$3.26Miss by $2.03Q3 2025-$1.75Beat by $0.20Q2 2025-$1.71Beat by $0.56Q1 2025-$2.59Beat by $1.32Q4 2024-$9.40Miss by $5.30

Ask the moment ENDRA Life Sciences Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did ENDRA Life Sciences Inc. report Q1 2026 earnings?
ENDRA Life Sciences Inc. (NDRA) reported Q1 2026 earnings on May 18, 2026 before market open.
What were ENDRA Life Sciences Inc.'s Q1 2026 revenue and EPS?
ENDRA Life Sciences Inc. reported eps of $-1.09 for Q1 2026.
Did ENDRA Life Sciences Inc. beat estimates in Q1 2026?
EPS beat the consensus estimate of $-1.23 by $0.14.
How did ENDRA Life Sciences Inc.'s Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 57.9% from $-2.59.
Where can I find ENDRA Life Sciences Inc.'s Q1 2026 SEC filings?
You can read the 10-K periodic report (0001213900-26-037617) directly on SEC EDGAR. The filing index links above go to sec.gov.